IRIS Accounts Production v24.3.0.553 10886317 director 1.4.23 31.3.24 31.3.24 26/11/2024 0 0 true false true false false true true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108863172023-03-31108863172024-03-31108863172023-04-012024-03-31108863172022-03-31108863172022-04-012023-03-31108863172023-03-3110886317ns15:EnglandWales2023-04-012024-03-3110886317ns14:PoundSterling2023-04-012024-03-3110886317ns10:Director12023-04-012024-03-3110886317ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110886317ns10:SmallEntities2023-04-012024-03-3110886317ns10:Audited2023-04-012024-03-3110886317ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110886317ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110886317ns10:FullAccounts2023-04-012024-03-3110886317ns10:CompanySecretary12023-04-012024-03-3110886317ns10:RegisteredOffice2023-04-012024-03-3110886317ns5:CurrentFinancialInstruments2024-03-3110886317ns5:CurrentFinancialInstruments2023-03-3110886317ns5:ShareCapital2024-03-3110886317ns5:ShareCapital2023-03-3110886317ns5:SharePremium2024-03-3110886317ns5:SharePremium2023-03-3110886317ns5:RetainedEarningsAccumulatedLosses2024-03-3110886317ns5:RetainedEarningsAccumulatedLosses2023-03-3110886317ns5:CostValuation2023-03-31
REGISTERED NUMBER: 10886317 (England and Wales)















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024

FOR

PTG TREATMENTS HOLDINGS LIMITED

PTG TREATMENTS HOLDINGS LIMITED (REGISTERED NUMBER: 10886317)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


PTG TREATMENTS HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTOR: S J Pope





SECRETARY: ICM Administration Limited





REGISTERED OFFICE: Ridge Court
The Ridge
Epsom
Surrey
KT18 7EP





REGISTERED NUMBER: 10886317 (England and Wales)





AUDITORS: Lewis Brownlee (Chichester) Limited
Chartered Accountants
Statutory Auditors
Appledram Barns
Birdham Road
Chichester
West Sussex
PO20 7EQ

PTG TREATMENTS HOLDINGS LIMITED (REGISTERED NUMBER: 10886317)

BALANCE SHEET
31 MARCH 2024

2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 3,000,000 3,000,000

CURRENT ASSETS
Debtors 5 100,000 7,634

CREDITORS
Amounts falling due within one year 6 100,076 3,450
NET CURRENT (LIABILITIES)/ASSETS (76 ) 4,184
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,999,924

3,004,184

CAPITAL AND RESERVES
Called up share capital 200 200
Share premium 2,999,800 2,999,800
Retained earnings (76 ) 4,184
SHAREHOLDERS' FUNDS 2,999,924 3,004,184

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 November 2024 and were signed by:





S J Pope - Director


PTG TREATMENTS HOLDINGS LIMITED (REGISTERED NUMBER: 10886317)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

PTG Treatments Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in Sterling (£), which is also the functional currency of the Company. Monetary amounts in these Financial Statements are rounded to the nearest £1.

Going concern
The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

Preparation of consolidated financial statements
The financial statements contain information about PTG Treatments Holdings Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Investments in subsidiaries
Investments held as fixed assets are stated at cost or valuation less provision for any permanent diminution in value.

Financial instruments
Financial instruments are classified by the director as basic or advanced following the conditions in FRS 102 Section 11. Basic financial instruments are recognised at amortised cost using the effective interest method, unless the effect of discounting would be immaterial, in which case they are stated at cost. The company has no advanced financial instruments.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


PTG TREATMENTS HOLDINGS LIMITED (REGISTERED NUMBER: 10886317)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.


3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£
COST
At 1 April 2023
and 31 March 2024 3,000,000
NET BOOK VALUE
At 31 March 2024 3,000,000
At 31 March 2023 3,000,000

The directors have reviewed the investment at the balance sheet date and do not believe there to be a permanent diminution in value.

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Amounts owed by group undertakings 100,000 7,634

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£ £
Amounts owed to group undertakings 96,626 -
Other creditors 3,450 3,450
100,076 3,450

7. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Sam Ede BFP FCA FCCA (Senior Statutory Auditor)
for and on behalf of Lewis Brownlee (Chichester) Limited